Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.

Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome. Abstract Text:

M Kathryn Liszewski,Marilyn K Leung,Barbara Schraml,Timothy H J Goodship,John P Atkinson,

Mutations in complement regulatory proteins predispose to the development of aHUS. Approximately 50% of patients bear a mutation in one of three complement control proteins, factor H, factor I, or membrane cofactor protein (MCP; CD46). Another membrane regulator that is closely related to MCP, decay accelerating factor (DAF; CD55) thus far has shown no association with aHUS and continues to be investigated. The goal of this study was to compare the regulatory profile of MCP and DAF and to assess how alterations in MCP predispose to complement dysregulation. We employed a model system of complement activation on Chinese hamster ovary (CHO) cell transfectants. The four regularly expressed isoforms of MCP and DAF inhibited C3b deposition by the alternative pathway. DAF, but not MCP, inhibited the classical pathway. Most patients with MCP-aHUS are heterozygous and express only 25-50% of the wild-type protein. We, therefore, analyzed the effect of reduced levels of wild-type MCP and found that cells with lowered expression levels were less efficient in inhibiting alternative pathway activation. Further, a dysfunctional MCP mutant, expressed at normal levels and identified in five patients with aHUS (S206P), failed to protect against C3b amplification on CHO cells, even if expression levels were increased 10-fold. Our results add new information relative to the necessity for appropriate expression levels of MCP and further implicate the alternative pathway in disease processes such as aHUS.

Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome. Publishing Authors By Initials

MK Liszewski,MK Leung,B Schraml,TH Goodship,JP Atkinson,

For similar proteins: protein isoforms research abstracts see: proteins: protein isoforms research

PUBMED ID PMID:

MEDLINE DATE:

Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Molecular immunology

VOLUME: 44

Page Numbers: 1559-68

Journal Abbreviation: Mol. Immunol.

ISSN: 0161-5890

DAY: 5

MONTH: 10

YEAR: 2006

Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7905289

Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome. Keywords Mesh Terms:

KEYWORDS: Protein Isoforms

MESH TERMS: metabolism

Chemical & Substance for Abstract: Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome. Information

Substance Name: Complement Factor H

Registry Number: 80295-65-4

Grant and Affiliation Information for Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.

AFFILIATION: Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8045, St. Louis, MO 63110, USA.

Country: England

AGENCY: United States NIAID

GRANT: R01 AI37618

ACRONYM: AI

MEDLINETA: Mol Immunol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome Related Publications

• Acute changes in cardiovascular function during the onset period of daytime sleep: comparison to lying awake and standing.
• Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
• Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
• Computer automated movement detection for the analysis of behavior.
• Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I.
• Cutting edge: treatment of complement regulatory protein deficiency by retroviral in vivo gene therapy.
• Developing a Questionnaire to Measure Perceived Attributes of eHealth Innovations.
• Development of brain mechanisms for visual global processing and object segmentation.
• Drug-induced epigenetic changes produce drug tolerance.
• Epidemiology of hip fractures in Belgrade, Serbia Montenegro, 1990-2000.
• Grounded theory research: literature reviewing and reflexivity.
• Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
• International journal of sports medicine: progress and innovation in cycling science 2001-2007.
• Introduction and Overview: 470: 9:00 AM-9:05 AM.
• Is hepatitis C infection associated with increased risk of depression in persons with methamphetamine dependence?
• Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.
• Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLS.
• Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.
• Outcomes of primary thyroid non-Hodgkin's lymphoma: a series of nine consecutive cases.
• Overview of emergency medical services in North Carolina.
• Physical Activity and Shiftwork: 473: 9:55 AM-10:20 AM.
• Post-Exercise Cardiac TVoponin T: A Meta-Analysis: 1745: Board #33 May 31 9:00 AM 10:30 AM.
• Reversible reproductive control in harbour seals (Phoca vitulina) with a gonadotropin-releasing hormone agonist.
• Risk reduction strategies in ischaemic stroke : the role of antiplatelet therapy.
• Semantic interference and associative facilitation from words presented in rapid serial visual presentation.
• Systemic humoral autoimmunity but joint-specific inflammation: the syndrome of rheumatoid arthritis.
• Testis-specific expression of the beta2 tubulin promoter of Aedes aegypti and its application as a genetic sex-separation marker.
• The effects of single and repeated bouts of soccer-specific exercise on salivary IgA.
• The nutritional effects of endoscopic intubation for carcinoma of the oesophagus or cardia.
• Using two-component systems and other bacterial regulatory factors for the fabrication of synthetic genetic devices.